Scientific Program

This scientific program is preliminary and will be updated in the coming months

Key lectures

Hall ISGE Key Lecture 13:33-14:33
Bruno Lunenfeld Lecture: Understanding sex Hormones and breast cancer
  • Richard Santen (US)
    Understanding sex Hormones and breast cancer
Hall ISGE Key Lecture 13:33-14:33
Emergency contraception
  • Kristina Gemzell Danielsson (SE)
    Emergency contraception
Hall ISGE Key Lecture 13:33-14:33
Fred Naftolin Lecture: Estrogens for the prevention and management of osteoporosis: State of the art in 2026
  • Jean Yves Reginster (BE)
    Estrogens for the prevention and management of osteoporosis: State of the art in 2026
Hall ISGE Key Lecture 13:33-14:33
Menopause and the heart
  • Angela Maas (NL)
    Menopause and the heart
Hall ISGE Key Lecture 13:33-14:33
Presidential Lecture: 40 years of gynecological endocrinology: from the past to the future
  • Andrea Riccardo Genazzani (IT)
    40 years of gynecological endocrinology: from the past to the future
Hall ISGE Key Lecture 13:33-14:33
Sex steroids, metabolism and diabetes
  • Franck Mauvais-Jarvis (US)
    Sex steroids, metabolism and diabetes
Hall ISGE Key Lecture 13:33-14:33
The evolution of gynecologic oncology
  • Pier Luigi Benedetti Panici (IT)
    The evolution of gynecologic oncology
Hall ISGE Key Lecture 13:33-14:33
The role of AMH in female reproductive health: past, present and future
  • Bart Fauser (NL)
    The role of AMH in female reproductive health: past, present and future
Hall ISGE Key Lecture 13:33-14:33
The science of implantation
  • Carlos Simon (ES)
    The science of implantation

Symposia

Hall ISGE Symposium 13:33-14:33
A modern view of PCOS
  • Alessandro Genazzani (IT)
    The neuroendocrine loop of PCOS
  • Francis De Zegher (BE)
    Early development of adolescent PCOS
  • Lourdes Ibáñez (ES)
    Diagnosis and future treatments of adolescent PCOS
  • Petra Stute (CH)
    Features and challenges in the management of PCOS in migrants
Hall ISGE Symposium 13:33-14:33
Adolescent gynecological endocrinology
  • Zoran Stankovic (RS)
    Challenges in modern pediatric and adolescent gynecology
  • Charles Sultan (FR)
    Adult consequences of female precocious puberty
  • Žana Bumbulienė (LT)
    Navigating the Maze of Adolescent Uterine Bleeding
  • Efthimios Deligeoroglou (GR)
    PCOS in lean adolescents
Hall ISGE Symposium 13:33-14:33
Brain Aging and woman’s health
  • Claudio Soares (CA)
    Menopause, mood and depression
  • Walter Rocca (US)
    Premature or early menopause and risk of neurodegenerative diseases
  • Herman Depypere (BE)
    Is there a link between MHT and dementia?
Hall ISGE Symposium 13:33-14:33
Difficult contraceptive care
  • Gabriele Merki (CH)
    Contraception in women with multiple sclerosis
  • Giovanni Grandi (IT)
    Contraception in women at increased thromboembolic risk
  • Nestor Siseles (AR)
    Contraception and comorbidities in the menopausal transition
  • David Vasquez Awad (CO)
    Contraception and cancer
Hall ISGE Symposium 13:33-14:33
Endocrine disorders and woman’s health
  • Elene Asanidze (GR)
    Complete Androgen Insensitivity Syndrome: Complexities in Diagnosis, Management, and Long-Term Follow-Up
  • Elena Armeni (GR)
    The thyroid gland and woman’s health
  • Andrzej Milewicz (PL)
    How vitamine D deficiency influence on obesity and diabetes mellitus type 2
Hall ISGE Symposium 13:33-14:33
Endometriosis and Adenomyosis
  • Ludwig Kiesel (DE)
    Understanding the basis of endometriosis and adenomyosis
  • Felice Petraglia (IT)
    The evolution of medical treatments for endometriosis and adenomyosis
  • Tevfik Yoldemir (TR)
    Endometriosis in Perimenopause and postmenopause
  • Stefano Angioni (IT)
    Fertility-sparing endometriosis surgery
Hall ISGE Symposium 13:33-14:33
Frontiers of medically-assisted procreation
  • Filippo Ubaldi (IT)
    The DuoStim concept
  • Pedro Barri (ES)
    Progesterone-primed ovarian stimulation
  • Nicola Pluchino (CH)
    Effect of IVF on pain and quality of life in women with endometriosis
  • Inmaculada Moreno Gimeno (ES)
    The impact of the microbiome in reproductive health
Hall ISGE Symposium 13:33-14:33
Health Consequences of functional hypothalamic amenorrhea
  • Sarah Berga (US)
    Stress weight and reproductive function
  • Chrisandra Shufelt (US)
    The silent impact of stress: health consequences of FHA
  • Rosanna Apa (IT)
    Irisin and Bone Status in FHA: there is a role for post-menopausal osteoporosis
Hall ISGE Symposium 13:33-14:33
Highlights on osteoporosis
  • Antonio Cano (ES)
    Bone anabolic drugs, the other pathway in bone metabolism
  • Florence Tremollieres (FR)
    MHT and the bone
  • Santiago Palacios (ES)
    Are SERMs outdated?
  • Mark Brincat (MT)
    The intervertebral disk: the silent problem
Hall ISGE Symposium 13:33-14:33
Hormones and cancer
  • Frederick Naftolin (US)
    p80, a novel protein in cancer biology, recognition and management
  • Valentina Bounous (IT)
    Menopause after breast cancer
  • Jennifer Sassarini (GB)
    Managing menopause after gynecological cancer
  • Irene Lambrinoudaki (GR)
    Bone health after breast cancer
Hall ISGE Symposium 13:33-14:33
Menopause and the heart
  • Nicolas Mendoza (ES)
    Exercise and health after menopause
  • Peter Chedraui (EC)
    Metabolic changes and CVD across the menopausal transition
  • Peter Collins (GB)
    Microvascular angina and menopause
  • John Stevenson (GB)
    HRT in women with established coronary disease
Hall ISGE Symposium 13:33-14:33
Modern concepts in ovarian cancer
  • Marta Caretto (IT)
    Contraception and MHT in women with BRCA 1/2 mutations
  • Dirk Timmerman (BE)
    State-of-the-Art Diagnostic Approaches in Ovarian Cancer
  • Roberto Tozzi (IT)
    The evolution of mini-invasive surgery for ovarian cancer
Hall ISGE Symposium 13:33-14:33
Modern contraception
  • Cuauhtemoc Celis (MX)
    Combined hormonal contraception for abnormal uterine bleeding
  • Manuela Farris (IT)
    Overcoming barriers to hormonal contraception
  • Nilson De Melo (BR)
    Modern contraception in Latin America
Hall ISGE Symposium 13:33-14:33
Neuroendocrinology revisited
  • Blazej Meczekalski (PL)
    Kisspeptin and Neurokinin B - potential therapeutic roles role in gynecological endocrinology
  • Rossella Nappi (IT)
    Neuroendocrine substrates of sexuality in women
  • Regine Sitruk Ware (US)
    Progesterone, progestins and the brain
Hall ISGE Symposium 13:33-14:33
Obstetric Endocrinology
  • Howard J. A. Carp (IL)
    Recurrent Miscarriage - The resistant patient
  • Gian Carlo Di Renzo (IT)
    Current gaps in prevention and predition of preterm birth
  • Herbert Valensise (IT)
    Current concepts on fetal growth restriction
Hall ISGE Symposium 13:33-14:33
The endometrium
  • Caterina Exacoustos (IT)
    Modern endometrial imaging
  • Angelica Linden Hirschberg (SE)
    The latest about breast and endometrial safety for bioidentical progesterone in MHT
  • Andrea Giannini (IT)
    Hormonal and metabolic control of endometrial hyperplasia and cancer
  • Francesco Fanfani (IT)
    Modern management of endometrial cancer
Hall ISGE Symposium 13:33-14:33
The gynecologic impact of uterine disorders
  • Steven Goldstein (US)
    Understanding endometrial function and dysfunction: the role of ultrasounds
  • Stefano Luisi (IT)
    Modern medical management of myomas
  • Leila Adamyan (RU)
    Complex uterine surgery
  • Camil Castelo-Branco (ES)
    Can we create custom/tailored neovaginas in (Rokitanskys-Morrisa)?
Hall ISGE Symposium 13:33-14:33
The troubled journey of the menopausal transition
  • Panagiotis Anagnostis (GR)
    Is early menopause a different entity than POI?
  • Roberta Brinton (US)
    The stages of the menopausal transition and its implications for hormone therapy intervention
  • Tommaso Simoncini (IT)
    Understanding the clinical journey of the menopausal transition
  • Stavroula Paschou (GR)
    Obesity across menopause
Hall ISGE Symposium 13:33-14:33
Understanding and managing infertility
  • Eileen Manalo (PH)
    Managing fertility in the late reproductive years
  • Basil Tarlatzis (GR)
    Ovarian stimulation: does the type of gonadotropin matter?
  • Antonio Pellicer (ES)
    How IVF affects the risks of pregnancy
  • Luca Gianaroli (IT)
    Oocyte donation: is it the solution?

Therapeutic forum

Hall ISGE Therapeutic Forum 13:33-14:33
Medical strategies to achieve ovulation induction
  • Basil Tarlatzis (GR)
    Medical strategies to achieve ovulation induction
Hall ISGE Therapeutic Forum 13:33-14:33
Medical strategies to manage stress-related cycle disorders
  • Blazej Meczekalski (PL)
    Medical strategies to manage stress-related cycle disorders
Hall ISGE Therapeutic Forum 13:33-14:33
Medical strategies to manage women with POI
  • Svetlana Vujovic (RS)
    Medical strategies to manage women with POI

Meet the experts

Hall ISGE Meet the Expert 13:33-14:33
Breast cancer
  • Alfred Mueck (DE)
    Can screening reduce the breast cancer risk induced by HRT?
  • Anne Gompel (FR)
    Endocrine challenges of breast cancer survivors
Hall ISGE Meet the Expert 13:33-14:33
Family planning in a changing World
  • Xiangyan Ruan (CN)
    Hormonal contraception: Asian vs. Western World
  • Martin Birkhaeuser (CH)
    Hormonal contraception in an ageing World
Hall ISGE Meet the Expert 13:33-14:33
From GSM to pelvic floor dysfunction
  • Eleonora Russo (IT)
    Understanding bladder function through menopause and ageing
  • Tim Hillard (GB)
    Menopause and urinary incontinence, the way to go
Hall ISGE Meet the Expert 13:33-14:33
Hormones and psyche
  • Katie Marwik (GB)
    The role of the menstrual cycle on psychiatric disorders
  • Peter Schmidt (US)
    The neurobiological basis of post-partum depression and PMDD
Hall ISGE Meet the Expert 13:33-14:33
Precision menopause hormone therapy
  • Paula Briggs (GB)
    Personalizing contraception at the menopausal transition
  • Pluvio Coronado (ES)
    Modern tools to assess eligibility and response to MHT
Hall ISGE Meet the Expert 13:33-14:33
The challenges of premature ovarian insufficiency
  • Svetlana Vujovic (RS)
    Role of adrenal and ovarian androgen steroid levels in premature ovarian insufficiency
  • Kenny Rodriguez Wallberg (SE)
    Fertility Preservation for patients with Turner syndrome and high risk of POI

Debates

Hall ISGE Debate 13:33-14:33
Gender dysphoria: current ethical and medical challenges
  • Kai Haldre (EE)
    Gender dysphoria: current ethical and medical challenges
  • Alessandra Fisher (IT)
    Gender dysphoria: current ethical and medical challenges
Hall ISGE Debate 13:33-14:33
Is decreased sexual function a disease?
  • Salvatore Caruso (IT)
    Is decreased sexual function a disease?
  • Johannes Bitzer (CH)
    Is decreased sexual function a disease?
Hall ISGE Debate 13:33-14:33
Ovarian cancer screening: is it feasible?
  • TBD (AF)
    Ovarian cancer screening: is it feasible?
  • Anna Fagotti (IT)
    Ovarian cancer screening: is it feasible?

Isge scholarship courses

Hall ISGE ISGE Scholarship course 13:33-14:33
Course 1
  • Frederick Naftolin (US)
    The biological basis of ovulation
  • Sarah Berga (US)
    The neuroendocrine mysteries of hypothalamic amenorrhea
  • Angelica Linden Hirshberg (SE)
    Why muscle and fat are important for the menstrual cycle
Hall ISGE ISGE Scholarship course 13:33-14:33
Course 2
  • Nilson De Melo (BR)
    The history of hormonal contraception
  • Xiangyan Ruan (CN)
    Management of infertility in PCOS
  • Peter Chedraui (EC)
    Diagnosis and management of hypertensive disorders of pregnancy
Hall ISGE ISGE Scholarship course 13:33-14:33
Course 3
  • Leyla Adamyan (RU)
    The role of surgery in endometriosis
  • Nicola Pluchino (CH)
    Preserving and fostering fertility in endometriosis
  • Nestor Siseles (AR)
    The evolution of menopause hormone therapy